These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19138331)

  • 1. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal damage markers in cerebrospinal fluid are increased in ALS.
    Brettschneider J; Petzold A; Süssmuth SD; Ludolph AC; Tumani H
    Neurology; 2006 Mar; 66(6):852-6. PubMed ID: 16567701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Terzi M; Birinci A; Cetinkaya E; Onar MK
    Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.
    Valentino F; Bivona G; Butera D; Paladino P; Fazzari M; Piccoli T; Ciaccio M; La Bella V
    Eur J Neurol; 2010 Jan; 17(1):84-9. PubMed ID: 19659753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
    Tortelli R; Copetti M; Ruggieri M; Cortese R; Capozzo R; Leo A; D'Errico E; Mastrapasqua M; Zoccolella S; Pellegrini F; Simone IL; Logroscino G
    Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.
    Süssmuth SD; Tumani H; Ecker D; Ludolph AC
    Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
    Chełstowska B; Kuźma-Kozakiewicz M
    Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
    Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis.
    Lanznaster D; Hergesheimer RC; Bakkouche SE; Beltran S; Vourc'h P; Andres CR; Dufour-Rainfray D; Corcia P; Blasco H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
    Iłecka J
    J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid tau protein in multiple sclerosis.
    Kapaki E; Paraskevas GP; Michalopoulou M; Kilidireas K
    Eur Neurol; 2000; 43(4):228-32. PubMed ID: 10828654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.